{"title":"Engineering Fibroblast Growth Factor-2 (FGF2) Production in Cyanobacteria.","authors":"Bharat Kumar Majhi, Anastasios Melis","doi":"10.1021/acssynbio.5c00388","DOIUrl":null,"url":null,"abstract":"<p><p>The Fibroblast Growth Factor 2 (FGF2) is an important signaling protein that serves to activate a variety of biological processes in animal and human cells. The FGF2 comprises an uncommon β-barrel structure composed of β-pleated sheets and loops only. It functions as a multipurpose protein involved in cell growth, division, and repair. Accordingly, FGF2 is important in the biopharmaceutical/biomedical, as well as applied research fields. However, stable FGF2 expression and isolation in heterologous systems is hindered by the exclusively β-sheet structure of this protein. <i>Synechocystis</i> sp. PCC 6803 is a freshwater, single-celled cyanobacterium serving as a model organism in photosynthesis and synthetic biology research. To stabilize and enhance accumulation of FGF2 in <i>Synechocystis</i>, the codon-optimized FGF2 gene was installed as a fusion construct with the highly expressed CpcB β-subunit of phycocyanin. This enabled stable recombinant FGF2 accumulation in <i>Synechocystis</i>, overcoming the difficulty due to the occurrence of β-sheets only in the structure of this protein. Furthermore, the recombinant phycocyanin-FGF2 fusion protein (Phyco*FGF2) exhibited both phycocyanin and FGF2 bioactivity. The work supports the concept that cyanobacterial cells will tolerate difficult-to-express heterologous recombinant proteins when fused to phycocyanin, as the latter is needed for photosynthesis and cellular growth, thus enabling a stoichiometric accumulation, in this case between phycocyanin and the FGF2 protein.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":" ","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Synthetic Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1021/acssynbio.5c00388","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
The Fibroblast Growth Factor 2 (FGF2) is an important signaling protein that serves to activate a variety of biological processes in animal and human cells. The FGF2 comprises an uncommon β-barrel structure composed of β-pleated sheets and loops only. It functions as a multipurpose protein involved in cell growth, division, and repair. Accordingly, FGF2 is important in the biopharmaceutical/biomedical, as well as applied research fields. However, stable FGF2 expression and isolation in heterologous systems is hindered by the exclusively β-sheet structure of this protein. Synechocystis sp. PCC 6803 is a freshwater, single-celled cyanobacterium serving as a model organism in photosynthesis and synthetic biology research. To stabilize and enhance accumulation of FGF2 in Synechocystis, the codon-optimized FGF2 gene was installed as a fusion construct with the highly expressed CpcB β-subunit of phycocyanin. This enabled stable recombinant FGF2 accumulation in Synechocystis, overcoming the difficulty due to the occurrence of β-sheets only in the structure of this protein. Furthermore, the recombinant phycocyanin-FGF2 fusion protein (Phyco*FGF2) exhibited both phycocyanin and FGF2 bioactivity. The work supports the concept that cyanobacterial cells will tolerate difficult-to-express heterologous recombinant proteins when fused to phycocyanin, as the latter is needed for photosynthesis and cellular growth, thus enabling a stoichiometric accumulation, in this case between phycocyanin and the FGF2 protein.
期刊介绍:
The journal is particularly interested in studies on the design and synthesis of new genetic circuits and gene products; computational methods in the design of systems; and integrative applied approaches to understanding disease and metabolism.
Topics may include, but are not limited to:
Design and optimization of genetic systems
Genetic circuit design and their principles for their organization into programs
Computational methods to aid the design of genetic systems
Experimental methods to quantify genetic parts, circuits, and metabolic fluxes
Genetic parts libraries: their creation, analysis, and ontological representation
Protein engineering including computational design
Metabolic engineering and cellular manufacturing, including biomass conversion
Natural product access, engineering, and production
Creative and innovative applications of cellular programming
Medical applications, tissue engineering, and the programming of therapeutic cells
Minimal cell design and construction
Genomics and genome replacement strategies
Viral engineering
Automated and robotic assembly platforms for synthetic biology
DNA synthesis methodologies
Metagenomics and synthetic metagenomic analysis
Bioinformatics applied to gene discovery, chemoinformatics, and pathway construction
Gene optimization
Methods for genome-scale measurements of transcription and metabolomics
Systems biology and methods to integrate multiple data sources
in vitro and cell-free synthetic biology and molecular programming
Nucleic acid engineering.